Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

Edaravone ALS Study Group

Research output: Contribution to journalArticlepeer-review

190 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients'. Together they form a unique fingerprint.

Medicine & Life Sciences